Loading ...

Efficacy of Tezepelumab in Peanut Allergy

(

ZENITH

)

ITN Protocol #:

ITN097AD

Branded Name:

ZENITH

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Allergy & Asthma

Current Status:

Development

Summary:

Efficacy of Tezepelumab in Peanut Allergy: a Double-Blind, Randomized, Placebo-controlled Trial

Clinical Operations Associate Director

Clinical Operations Manager

ITN Biologist

ITN Clinical Trial Physician

NIAID Project Manager

NIAID Regulator Officer

Rho Data Manager

Rho Scientist

PPD Lead Monitor

Study Personnel:

Protocol Chair

Edwin Kimedwinkim@med.unc.edu

Work: 

919-962-4409

Protocol Chair

Audrey Ploughaplough@immunetolerance.org

Work: 

415-278-0709

Protocol Chair

MacKenzie Coxmcox@immunetolerance.org

Work: 

415-939-7249

Protocol Chair

Carolyn Baloh, MDcbaloh@immunetolerance.org

Work: 

412-508-5216

Protocol Chair

Paul Price, PhDpaul.price@nih.gov

Work: 

301-761-7835

Protocol Chair

Lars Dunaway, PhDLars_Dunaway@rhoworld.com

Work: 

(919) 595-6382